Raul Santos: It’s Time Science Wins the War Against Bad Opinions and Lies on Statins
Raul Santos, Researcher at ARO, Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he co-authored with Timo Strandberg, adding:
”In this editorial, written by Timo Strandberg and me in the The Lancet, we comment on the most recent CTT meta-analysis on statin safety. Statins have changed how we practice preventive medicine: these drugs prevent myocardial infarction and stroke, reduce ischemia and the need for revascularization, and prolong life! Statins, as well as cholesterol reduction, are safe; this was clearly shown by the Oxford group’s robust patient-level meta-analysis.
Indeed, statins may raise glucose levels, and patients with prediabetes may pass the diagnosis threshold and develop diabetes; also, elevations in AST/ALT without clinical significance may occur. Finally, statins may cause tubular proteinuria (reduction in absorption) and mild edema; however, these are rare and of no clinical significance. It’s about time science wins the war against bad opinions and lies!՛՛
Title: Product labels downplay the safety of statin therapy: evidence from randomised controlled trials
Authors: Timo E Strandberga, Raul D Santos
Read the Full Article on The Lancet.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO